PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-20.58%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-40.39%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-41.75%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-41.75%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-63.52%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-63.08%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-62.83%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-1.29%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.63%
Reduced diluted shares while OBE is at 1.77%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
13.73%
Dividend growth of 13.73% while OBE is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
22.06%
Positive OCF growth while OBE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-11.41%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
44.06%
Positive 10Y revenue/share CAGR while OBE is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
54.52%
5Y revenue/share CAGR 1.25-1.5x OBE's 42.60%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
2.64%
3Y revenue/share CAGR under 50% of OBE's 101.26%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
88.97%
Positive long-term OCF/share growth while OBE is negative. John Neff would see a structural advantage in sustained cash generation.
122.94%
5Y OCF/share CAGR above 1.5x OBE's 10.95%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
100.66%
3Y OCF/share CAGR similar to OBE's 95.85%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
167.57%
Net income/share CAGR 1.25-1.5x OBE's 126.25%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
156.51%
5Y net income/share CAGR 1.25-1.5x OBE's 140.87%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
23.02%
Below 50% of OBE's 103.64%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
0.40%
Positive growth while OBE is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
-7.34%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-17.62%
Negative 3Y equity/share growth while OBE is at 313.65%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-75.18%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
223.44%
Dividend/share CAGR of 223.44% while OBE is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
170.29%
3Y dividend/share CAGR of 170.29% while OBE is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-16.29%
Firm’s AR is declining while OBE shows 2.06%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
0.45%
Asset growth well under 50% of OBE's 2.44%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
4.01%
BV/share growth above 1.5x OBE's 2.32%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
4.12%
Debt shrinking faster vs. OBE's 14.48%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
-12.80%
We cut SG&A while OBE invests at 177.67%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.